$1.22 -0.05 (-3.94%)
Kairos Pharma, Ltd. (KAPA)
Kairos Pharma, Ltd. (KAPA) is a biotechnology company focused on the development of innovative pharmaceutical therapies. The company specializes in research and development aimed at addressing unmet medical needs through novel drug candidates and delivery systems in various therapeutic areas.
Company News
Kairos Pharma Closing of $6.2 Million Initial Public Offering
Kairos Pharma, a clinical-stage biopharmaceutical company, has closed its $6.2 million initial public offering. The company plans to use the proceeds to fund its Phase 1 and Phase 2 trials for its lead product candidate ENV 105 and advance its preclinical candidate KROS 101.